A new study has identified three existing medications that could be repurposed to treat or prevent Alzheimer's disease.

Novo Nordisk will soon announce the results of perhaps the most ambitious studies yet of its GLP-1 drug: whether it can help ...

The review synthesizes evidence on whether Alzheimer’s disease medications can improve neurocognitive outcomes in children ...

Novo Nordisk is expected to announce soon whether its blockbuster GLP-1 drug semaglutide can help slow Alzheimer’s disease ...

In a new study, scientists discovered two FDA-approved cancer drugs that could also be effective at combatting one well-known ...

A new study shows that lecanemab, an amyloid-clearing Alzheimer’s therapy, does not improve the brain’s waste-removal network ...

Study found drugs used to prevent shingles and treat erectile dysfunction could be promising for Alzheimer’s patients ...

The following guide offers a detailed overview of several classes of medications that research links to a higher risk of ...

A FREE NHS jab could be the most promising drug yet to stop Alzheimer’s, experts say. Two other medicines, to treat erectile dysfunction and motor neurone disease, also showed strong potential.

Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering ...

Eli Lilly receives CDSCO approval for donanemab, a new Alzheimer's treatment targeting early symptomatic stages of the ...